Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Articaine Volume Comparison in Irreversible Pulpitis
NCT06119139Unknown
- Sponsor
- Cairo University
- Start
- Dec 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
01
Overview
Randomised trial of articaine in irreversible pulpitis (2 arms), sponsored by Cairo University. Primary endpoint: Anesthetic success. Status: unknown.
02
Drugs
articaine
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT06119139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06119139.